Recently, the clinical trial application of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") for HS-20094, an independ...

On June 2, Synexis, a partner of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company"), announced that the innovative antif...

Recently, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or "Company") received the Notice of Approval for Clinical Trial of Drug from...

Recently, the Chinese Diabetes Society ("CDS") released the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition) ("C...

 Recently, the marketing approval application of Ameile (Almonertinib Mesilate Tablets), Class 1 innovative drug independently developed by Jiangsu Ha...

Recently, "Create Excellence in China with Ameile - 2nd CSCO Hansoh Pharma Lung Cancer Precision Diagnosis and Treatment Forum" was held simultaneousl...

Efforts bring happiness; hard work leads to great results On the occasion of the International Workers' Day Hansoh Pharma salutes all hardworking work...

On April 28, People's Daily Health Client and Health Times published a series of honorary lists including the 13th Health China Forum · Breakthrough N...